Cells,
Год журнала:
2023,
Номер
12(9), С. 1296 - 1296
Опубликована: Май 2, 2023
Senescent
cell
accumulation
has
been
observed
in
age-associated
diseases
including
cardiovascular
diseases.
cells
lack
proliferative
capacity
and
secrete
senescence-associated
secretory
phenotype
(SASP)
factors
that
may
cause
or
worsen
many
Therapies
targeting
senescent
cells,
especially
senolytic
drugs
selectively
induce
removal,
have
shown
to
delay,
prevent,
alleviate,
treat
multiple
preclinical
models.
Some
clinical
trials
already
completed
are
underway
for
a
number
of
geriatric
syndromes.
Understanding
how
cellular
senescence
affects
the
various
types
system,
such
as
endothelial
vascular
smooth
muscle
fibroblasts,
immune
progenitor
cardiomyocytes,
is
important
facilitate
translation
senotherapeutics
into
interventions.
This
review
highlights:
(1)
characteristics
their
involvement
diseases,
focusing
on
aforementioned
types,
(2)
evidence
about
other
senotherapeutics,
(3)
future
path
potential
Aging
is
a
gradual,
continuous
series
of
natural
changes
in
biological,
physiological,
immunological,
environmental,
psychological,
behavioral,
and
social
processes.
entails
the
immune
system
characterized
by
decrease
thymic
output
naïve
lymphocytes,
an
accumulated
chronic
antigenic
stress
notably
caused
infections
such
as
cytomegalovirus
(CMV),
cell
senescence
with
acquisition
inflammatory
senescence-associated
secretory
phenotype
(SASP).
For
this
reason,
due
to
SASP
originating
from
other
tissues,
aging
commonly
accompanied
low-grade
inflammation,
termed
"inflammaging".
After
decades
accumulating
evidence
regarding
age-related
processes
domain
now
appears
mature
enough
allow
integrative
reinterpretation
old
data.
Here,
we
provide
overview
topics
discussed
recent
workshop
"Aging
Chronic
Inflammation"
which
many
major
players
field
contributed.
We
highlight
advances
systematic
measurement
interpretation
biological
markers
aging,
well
their
implications
for
human
health
longevity
interventions
that
can
be
envisaged
maintain
or
improve
function
older
people.
Life Medicine,
Год журнала:
2022,
Номер
1(2), С. 103 - 119
Опубликована: Авг. 9, 2022
Abstract
Aging
is
a
natural
but
relentless
process
of
physiological
decline,
leading
to
physical
frailty,
reduced
ability
respond
stresses
(resilience)
and,
ultimately,
organismal
death.
Cellular
senescence,
self-defensive
mechanism
activated
in
response
intrinsic
stimuli
and/or
exogenous
stress,
one
the
central
hallmarks
aging.
Senescent
cells
cease
proliferate,
while
remaining
metabolically
active
and
secreting
numerous
extracellular
factors,
feature
known
as
senescence-associated
secretory
phenotype.
Senescence
physiologically
important
for
embryonic
development,
tissue
repair,
wound
healing,
prevents
carcinogenesis.
However,
chronic
accumulation
persisting
senescent
contributes
host
pathologies
including
age-related
morbidities.
By
paracrine
endocrine
mechanisms,
can
induce
inflammation
locally
systemically,
thereby
causing
dysfunction,
organ
degeneration.
Agents
those
targeting
damaging
components
phenotype
or
inducing
apoptosis
exhibit
remarkable
benefits
both
preclinical
models
early
clinical
trials
geriatric
conditions.
Here
we
summarize
features
outline
strategies
holding
potential
be
developed
interventions.
In
long
run,
there
an
increasing
demand
safe,
effective,
clinically
translatable
senotherapeutics
address
healthcare
needs
current
settings
global
Cells,
Год журнала:
2023,
Номер
12(9), С. 1296 - 1296
Опубликована: Май 2, 2023
Senescent
cell
accumulation
has
been
observed
in
age-associated
diseases
including
cardiovascular
diseases.
cells
lack
proliferative
capacity
and
secrete
senescence-associated
secretory
phenotype
(SASP)
factors
that
may
cause
or
worsen
many
Therapies
targeting
senescent
cells,
especially
senolytic
drugs
selectively
induce
removal,
have
shown
to
delay,
prevent,
alleviate,
treat
multiple
preclinical
models.
Some
clinical
trials
already
completed
are
underway
for
a
number
of
geriatric
syndromes.
Understanding
how
cellular
senescence
affects
the
various
types
system,
such
as
endothelial
vascular
smooth
muscle
fibroblasts,
immune
progenitor
cardiomyocytes,
is
important
facilitate
translation
senotherapeutics
into
interventions.
This
review
highlights:
(1)
characteristics
their
involvement
diseases,
focusing
on
aforementioned
types,
(2)
evidence
about
other
senotherapeutics,
(3)
future
path
potential